Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet.
共同靶向 TGF-β 和 PD-L1 可使三阴性乳腺癌对实验性免疫原性顺铂-艾立布林双药化疗敏感
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI184422
Kalfeist Laura, Ledys Fanny, Petit Stacy, Poirrier Cyriane, Kada Mohammed Samia, Galland Loïck, Derangère Valentin, Ilie Alis, Rageot David, Aucagne Romain, Bellaye Pierre-Simon, Truntzer Caroline, Thibaudin Marion, Rialland Mickaël, Ghiringhelli François, Limagne Emeric, Ladoire Sylvain
